NUCRYST Pharmaceuticals Corp.

NCS-T

0.00
0.00 (0.00%)
This company is not ACTIVE.

Analysis and Opinions about NCS-T

Signal
Opinion
Expert
DON'T BUY
DON'T BUY
September 24, 2007
Their acne treatment was not approved previously by the FDA, but suddenly was in July.. The approval isn’t doing a great deal for it.
Show full opinionHide full opinion
Their acne treatment was not approved previously by the FDA, but suddenly was in July.. The approval isn’t doing a great deal for it.
PAST TOP PICK
PAST TOP PICK
August 3, 2007
(A Top Pick Aug 24/06. Down 79.5%.) Their cream for treating acne did not get approved by the FDA, but did get approval 2 weeks ago. It might still be interesting. Sold his holdings.
Show full opinionHide full opinion
(A Top Pick Aug 24/06. Down 79.5%.) Their cream for treating acne did not get approved by the FDA, but did get approval 2 weeks ago. It might still be interesting. Sold his holdings.
PAST TOP PICK
PAST TOP PICK
October 19, 2006
(A Top Pick Aug 24/06. Down 52%.) Something went wrong with silver ointment treatment. They are back with silver bandaging. Based on the bandaging, it will be trading at 8-9 X earnings.
Show full opinionHide full opinion
(A Top Pick Aug 24/06. Down 52%.) Something went wrong with silver ointment treatment. They are back with silver bandaging. Based on the bandaging, it will be trading at 8-9 X earnings.
TOP PICK
TOP PICK
August 24, 2006
The Silcryst bandaging spin off from Westaim (WED-T). (They still hold about 75%). Have developed/patented a technology for reducing nanotechnology silver to its crystalline level for application in ointments. Getting great revenues. Highly speculative.
Show full opinionHide full opinion
The Silcryst bandaging spin off from Westaim (WED-T). (They still hold about 75%). Have developed/patented a technology for reducing nanotechnology silver to its crystalline level for application in ointments. Getting great revenues. Highly speculative.
Showing 1 to 4 of 4 entries
  • «
  • 1
  • »

NUCRYST Pharmaceuticals Corp.(NCS-T) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for NUCRYST Pharmaceuticals Corp. is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

NUCRYST Pharmaceuticals Corp.(NCS-T) Frequently Asked Questions

What is NUCRYST Pharmaceuticals Corp. stock symbol?

NUCRYST Pharmaceuticals Corp. is a OTC stock, trading under the symbol NCS-T on the (). It is usually referred to as or NCS-T

Is NUCRYST Pharmaceuticals Corp. a buy or a sell?

In the last year, there was no coverage of NUCRYST Pharmaceuticals Corp. published on Stockchase.

Is NUCRYST Pharmaceuticals Corp. a good investment or a top pick?

NUCRYST Pharmaceuticals Corp. was recommended as a Top Pick by Michael Smedley on 2007-09-24. Read the latest stock experts ratings for NUCRYST Pharmaceuticals Corp..

Why is NUCRYST Pharmaceuticals Corp. stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is NUCRYST Pharmaceuticals Corp. worth watching?

In the last year 0 stock analysts on Stockchase covered NUCRYST Pharmaceuticals Corp.. The stock is worth watching.

What is NUCRYST Pharmaceuticals Corp. stock price?

On , NUCRYST Pharmaceuticals Corp. (NCS-T) stock closed at a price of $.